133876-92-3 CAS NO.133876-92-3

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier . 

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

1. Company Profile:

SINOWAY INDUSTRIAL CO.,LTD is a state-owned company and a professional supplier in exporting 

Pharmaceutical Raw and its intermediates, Cosmetic Raw Material, Healthcare Product from China

since 1987, about 35 years experiences to Europe, America and Southeast Asia. We have  gained very 

good reputation from all our customers in the world.

Custom manuafacturing is very strong from us.We have developed some new items together with 

our local universityand institute special  for our oversea clients for long term business under signing secret 

agreement.

2. Quality information for Nattokinase/ Natto Extract Powder CAS 133876-92-3

3. Use for Nattokinase/ Natto Extract Powder CAS 133876-92-3

Nattokinase can effectively remove blood clots in the human blood, and also has a good effect on hypertension, aging, stroke, muscle spasms and cardiovascular disease. Thrombus disease is one of the major diseases that seriously endanger human health, such as acute myocardial infarction. Chemicalbook has about 15 million people worldwide, and the potential market for thrombolysis drugs is about $2 billion. As A new generation of thrombolytic agent or health food, nattokinase, the active ingredient in NATTO, has an attractive and broad prospect in overcoming the shortcomings of poor oral performance, high price and many complications of thrombolytic drugs in China.